Vai al contenuto principale
xMedica

Cerca

164 studi corrispondono a questi filtri. Visualizzati 1–25 di 164 studi

Risultati della ricerca
Numero di registrazioneStudioStatoFaseArruolamentoCentri / paesiAnno di inizioUltimo aggiornamentoAzioni
NCT05827081Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 229 centri in totale · contatto disponibile

In reclutamentoFase 31400previsti229 / 16202418 set 2026
NCT03435796Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 222 centri in totale · contatto disponibile

In reclutamentoFase 2 / Fase 31541previsti222 / 22201818 set 2026
NCT07206056An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate cancer (mCRPC).

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 35 centri in totale · contatto disponibile

In reclutamentoFase 1 / Fase 2188previsti35 / 14202518 set 2026
NCT07181109Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adju…

Contatto Rivendicato

Centro più vicino: Hutchinson, Kansas, United States — a 36 km · 1153 centri in totale

In reclutamentoFase 311.000previsti1153 / 35202518 set 2026
NCT07220083A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by ch…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 307 centri in totale · contatto disponibile

In reclutamentoFase 3286previsti307 / 40202617 set 2026
NCT06393374Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 311 centri in totale

In reclutamentoFase 31530previsti311 / 31202417 set 2026
NCT06531824EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). Pe…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 557 centri in totale · contatto disponibile

In reclutamentoFase 311.000previsti557 / 20202417 set 2026
NCT07037459Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fract…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 657 centri in totale

In reclutamentoFase 35056previsti657 / 34202516 set 2026
NCT06819878A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 374 centri in totale

In reclutamentoFase 3600previsti374 / 38202516 set 2026
NCT07064473EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 1143 centri in totale · contatto disponibile

In reclutamentoFase 311.800previsti1143 / 51202516 set 2026
NCT04613596Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com…

Contatto Rivendicato

Centro più vicino: Kingman, Kansas, United States — a 28 km · 770 centri in totale · contatto disponibile

In reclutamentoFase 2 / Fase 3626previsti770 / 47202016 set 2026
NCT06581328A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months…

Contatto Rivendicato

Centro più vicino: Hutchinson, Kansas, United States — a 36 km · 101 centri in totale · contatto disponibile

In reclutamentoFase 4200previsti101 / 1202515 set 2026
NCT06423911Study of Olverembatinib (HQP1351) in Patients With CML-CP

Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure c…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 163 centri in totale

In reclutamentoFase 3333previsti163 / 16202415 set 2026
NCT06492616A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 567 centri in totale · contatto disponibile

In reclutamentoFase 34220previsti567 / 28202415 set 2026
NCT06033274Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pa…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 31 centri in totale

In reclutamento800previsti31 / 8202315 set 2026
NCT07779408Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the adjuvant improves vaccine effectiveness. The study will enroll healthy adults aged 18 years and over. Participants will receive 2 injections i…

Contatto Rivendicato

Centro più vicino: Newton, Kansas, United States — a 53 km · 16 centri in totale

In reclutamentoFase 1 / Fase 2640previsti16 / 1202615 set 2026
NCT06677060Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 957 centri in totale

In reclutamentoFase 311.300previsti957 / 35202515 set 2026
NCT05125302Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how sa…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 129 centri in totale

In reclutamentoFase 31059previsti129 / 2202214 set 2026
NCT05065216Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 86 centri in totale · contatto disponibile

In reclutamentoFase 2 / Fase 3728previsti86 / 10202114 set 2026
NCT06237452VE303 for Prevention of Recurrent Clostridioides Difficile Infection

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 (recurrent CDI) and…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 215 centri in totale

In reclutamentoFase 3852previsti215 / 24202414 set 2026
NCT07213778REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 36 centri in totale

In reclutamentoFase 32000previsti36 / 4202514 set 2026
NCT06561386A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 326 centri in totale · contatto disponibile

In reclutamentoFase 31000previsti326 / 31202414 set 2026
NCT06056830Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 34 centri in totale · contatto disponibile

In reclutamentoFase 3383previsti34 / 3202311 set 2026
NCT06307652Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapag…

Contatto Rivendicato

Centro più vicino: Wichita, Kansas, United States — a 43 km · 852 centri in totale

In reclutamentoFase 33850previsti852 / 39202411 set 2026
NCT07619131A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

This is a study to evaluate the effect on LDL-C and the safety and tolerability of FDC laroprovstat/rosuvastatin in LLT-naïve patients. Laroprovstat is a small molecule that reduces the amount of LDL-C in the blood. Laroprovstat and FDC laroprovstat/rosuvastatin are being developed for the treatment…

Contatto Rivendicato

Centro più vicino: Derby, Kansas, United States — a 54 km · 152 centri in totale

In reclutamentoFase 3600previsti152 / 11202610 set 2026

Filtri